An Epidemiological Study to Assess the Prevalence of Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Prevalence and severity of liver and cardiac iron overload in patients with transfusional siderosis (MDS, thalassaemia major and other anaemias).
Hepatic and cardiac iron overload in patients with transfusional siderosis (MDS, thalassaemia major and other anaemias) will be measured using MRI to measure both liver and cardiac iron loading (R2 by FerriScan and T2*, respectively). Values will be compared to published thresholds of iron overload to determine severity of transfusion siderosis in the patient population studied.
12 months - retrospective
No
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals
Australia: Human Research Ethics Committee
CICL670AAU05
NCT01736540
January 2013
August 2014
Name | Location |
---|